Novartis signs new agreement with BioNTech for COVID-19 vaccine fill and finish

Novartis signs new agreement with BioNTech for COVID-19 vaccine fill and finish

Submitted by admin on October 21, 2021 - 9:29am
Source: 
Biopharma Reporter
News Tags: 
Novartis
BioNTech
vaccines
COVID-19
drug manufacturing
Headline: 
Novartis signs new agreement with BioNTech for COVID-19 vaccine fill and finish
snippet: 

Novartis has signed a new initial agreement with BioNTech for COVID-19 vaccine manufacturing: with its sterile manufacturing facilities in Ljubljana, Slovenia, to fill at least 24 million doses in 2022.

Do Not Allow Advertisers to Use My Personal information